Vanguard Group Inc Clear Point Neuro, Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,248,393 shares of CLPT stock, worth $16.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,248,393
Previous 1,242,993
0.43%
Holding current value
$16.7 Million
Previous $13.9 Million
37.8%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding CLPT
# of Institutions
93Shares Held
7.57MCall Options Held
390KPut Options Held
28.7K-
Susquehanna International Group, LLP Bala Cynwyd, PA509KShares$6.83 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA409KShares$5.48 Million1.22% of portfolio
-
Black Rock Inc. New York, NY366KShares$4.91 Million0.0% of portfolio
-
Brown Advisory Inc333KShares$4.47 Million0.01% of portfolio
-
Cm Management, LLC290KShares$3.89 Million4.19% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $328M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...